Marel M, Pekárek Z, Skácel Z, Spásová I, Víchová M, Svandová E
klinika TRN 1. LF UK a VFN, Praha.
Cas Lek Cesk. 2004;143(9):598-603.
:The malignant stenoses complicate the course of the disease in about 50% of patients with lung tumors. Management of them can influence the quality of life of the afflicted. There is no general agreement about optimal methods of their therapy, of selection of the best methods and also there is only few data about survival of these patients.
130 patients with tumors stenoses of the airways were prospectively followed in the 1998-2003 period, 93 of them suffered from lung cancer. Besides other treatment of the tumor they underwent also interventional bronchoscopy (Nd YAG laser, electrocautery i.e.). The airways were opened completely in 62% of the set of patients. The interventional bronchoscopy was complicated in 9% of patients, 32 patients lived at the 31st December of 2003, 98 of them had died. One year survival was 23.1%, median survival of the whole set of patients was 7 months. The patients with lung cancer had significantly worse survival than patients with other types of lung tumors, 6 months versus 10 months. There were no significant survival differences of the whole set according to the achieved grade of recanalisation, or according the inclusion of the brachytherapy to the set of interventional methods. The patients with inserted stent had significantly worse prognosis than the those without stenting. To homogenize the study group, the subset of patients with epidermoid lung cancer in the stage IIIB were selected (n = 51). Significantly longer survival of patients with complete recanalisation, insignificant longer survival in patients who underwent also brachytherapy and significantly shorter survival in patients with stenting were proved in this subgroup of patients.
The interventional bronchoscopy has a low rate of complications and in most cases it has a palliative effect. The survival of patients is more influenced by the extension and the type of the tumor, their general status, polymorbidity, age etc. than by effect or selection of interventional bronchoscopical methods.
在约50%的肺肿瘤患者中,恶性狭窄会使病程复杂化。对其进行治疗会影响患者的生活质量。对于其最佳治疗方法、最佳方法的选择尚无普遍共识,而且关于这些患者的生存数据也很少。
1998年至2003年期间,对130例气道肿瘤狭窄患者进行了前瞻性随访,其中93例患有肺癌。除了对肿瘤进行其他治疗外,他们还接受了介入性支气管镜检查(如钕钇铝石榴石激光、电灼术)。62%的患者气道完全开通。9%的患者介入性支气管镜检查出现并发症,2003年12月31日时32例患者存活,98例患者死亡。一年生存率为23.1%,全体患者的中位生存期为7个月。肺癌患者的生存率明显低于其他类型肺肿瘤患者,分别为6个月和10个月。根据再通程度或介入治疗方法中是否包含近距离放疗,全体患者的生存率无显著差异。置入支架的患者预后明显比未置入支架的患者差。为使研究组同质化,选择了IIIB期肺鳞癌患者亚组(n = 51)。在该亚组患者中,证实完全再通的患者生存期明显更长,接受近距离放疗的患者生存期无明显延长,置入支架的患者生存期明显更短。
介入性支气管镜检查并发症发生率低,在大多数情况下具有姑息作用。患者的生存更多地受肿瘤的范围和类型、一般状况、多种疾病、年龄等因素影响,而非介入性支气管镜检查方法的效果或选择。